What does CUSIP 02155X106 represent in this 13F holders report?

CUSIP 02155X106 is the security identifier for ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR in Q2 2022?

6 institutional investors reported ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR for Q2 2022. Use the holders table for investor-level position and value details.

ALTERITY THERAPEUTICS LTD - SPONSORED ADR (ATHE)

CUSIP: 02155X106

Q2 2022 13F Holders as of 30 Jun 2022

Security type / class: Equity / SPONSORED ADR
Total 13F shares: 724,694
Total 13F value: $441,000
Share change: -55,277
SEC-reported price per share: $0.59
Number of holders: 6
Value change: -$48,894
Number of buys: 2
Number of sells: 6

Security key

02155X106

Report period

Q2 2022

Institutions

Top holders

ATHE full security history Ownership snapshot Full 13F holder table ALTERITY THERAPEUTICS LTD SEC filings ALTERITY THERAPEUTICS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

0/10

Latest evidence

31 Mar 2022

13F Highest disclosed value: $481,000 10 rows are not safely comparable across share classes. Showing 1-6 of 10 holder rows.

Quick read

MORGAN STANLEY has the largest disclosed position value at $481K.

0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Disclosed position value Top 5

MORGAN STANLEY $481K

ENVESTNET ASSET MANAGEMENT INC $67K

SUSQUEHANNA INTERNATIONAL GROUP, LLP $26K

CITADEL ADVISORS LLC $19K

Virtu Financial LLC $16K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 10 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	— denominator unverified	$481,000 579,964 shares	—	31 Mar 2022
ENVESTNET ASSET MANAGEMENT INC	13F Company 13F	— denominator unverified	$67,000 82,386 shares	—	31 Mar 2022
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	— denominator unverified	$26,000 31,884 shares	—	31 Mar 2022
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$19,000 23,576 shares	—	31 Mar 2022
Virtu Financial LLC	13F Company 13F	— denominator unverified	$16,000 19,590 shares	—	31 Mar 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$9,000 12,128 shares	—	31 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

724,694

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-4

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q2 2022 value	Value change	Value Chg %